Evidence map›Paper›PMID 40135939›Full record

ArticleThe Analyst2025

Detection of

Manu V S, Marco Tonelli, Bailey Bell, Alok K Sharma, Tim S Bugni, Gianluigi Veglia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Analyst, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manu V SDepartment of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA. vegli001@umn.edu.
Marco TonelliDepartment of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, Wisconsin, 53706, USA.
Bailey BellPharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI, USA.
Alok K SharmaNCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA.
Tim S BugniPharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI, USA.
Gianluigi VegliaDepartment of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA. vegli001@umn.edu.ORCID http://orcid.org/0000-0002-2795-6964

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
NMR User Program at NMRFAMR24GM141526 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Katherine Anne Henzler-Wildman · 2021 to 2026
$6.4M
NCI NIH HHS 75N91019D00024NIGMS NIH HHS R24 GM141526
6 · The paper itself

Abstract

Approximately 40% of bacterial and mammalian metabolites contain nitrogen-based chemical moieties such as amides, amines, and imines. The identification and quantification of these groups

Indexed as

Nuclear Magnetic Resonance, BiomolecularNitrogen IsotopesNitrogen-15Nitrogen Isotopes

Identifiers

PMID40135939
PMCPMC12395989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.